GURUFOCUS.COM » STOCK LIST » Technology » Software » Leidos Holdings Inc (NYSE:LDOS) » Definitions » 3-Year Sharpe Ratio

LDOS (Leidos Holdings) 3-Year Sharpe Ratio : 0.53 (As of Jul. 07, 2025)


View and export this data going back to 2006. Start your Free Trial

What is Leidos Holdings 3-Year Sharpe Ratio?

The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2025-07-07), Leidos Holdings's 3-Year Sharpe Ratio is 0.53.


Competitive Comparison of Leidos Holdings's 3-Year Sharpe Ratio

For the Information Technology Services subindustry, Leidos Holdings's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Leidos Holdings's 3-Year Sharpe Ratio Distribution in the Software Industry

For the Software industry and Technology sector, Leidos Holdings's 3-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Leidos Holdings's 3-Year Sharpe Ratio falls into.


;
;

Leidos Holdings 3-Year Sharpe Ratio Calculation

The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.


Leidos Holdings  (NYSE:LDOS) 3-Year Sharpe Ratio Explanation

The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Leidos Holdings 3-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Leidos Holdings's 3-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Leidos Holdings Business Description

Address
1750 Presidents Street, Reston, VA, USA, 20190
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.
Executives
Gregory R Dahlberg director 11951 FREEDOM DRIVE, RESTON VA 20190
Kovarik Robert C Jr director C/O ALLIANCE BANKSHARES CORPORATION, 14200 PARK MEADOW DR #200S, CHANTILLY VA 20151
Noel B Williams director 1750 PRESIDENTS STREET, RESTON VA 20190
Roy E Stevens officer: Chief of Business Development 11951 FREEDOM DRIVE, RESTON VA 20190
Surya N Mohapatra director 3 GIRALDA FARMS, MADISON NJ 07940
Gary Stephen May director 11951 FREEDOM DRIVE, RESTON VA 20190
Thomas Arthur Bell director, officer: CEO 1750 PRESIDENTS STREET, RESTON VA 20190
Susan M Stalnecker director TWO N NINTHST, ALLENTOWN PA 18101
David G Fubini director D.G. FUBINI CONSULTANTS, LLC, 80 SEARS ROAD, BROOKLINE MA 02445
Miriam E John director 7011 EAST AVENUE, LIVERMORE CA 94550
James Robert Moos officer: Group President 11951 FREEDOM DRIVE, RESTON VA 20190
Cindy Gruensfelder officer: Executive Vice President 1750 PRESIDENTS STREET, RESTON VA 20190
Kraemer Harry M Jansen Jr director DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Howe Jerald S Jr officer: Executive VP & General Counsel
Robert S Shapard director P O BOX 696000, SANANTONIO TX 782696000